Genomic analysis and personalized cancer therapy for metastatic colorectal cancer.

被引：0
|
作者：
Dang, Rajan Paul
Ang, Celina
Holcombe, Randall F.
Sung, Max W.
Cagan, Ross L.
Schadt, Eric
Posner, Marshall R.
Donovan, Michael J.
Winder, Lewis A.
Kahn, Adnan
Camille, Nadia
Davis, Claire R.
Smibert, Peter
Misiukiewicz, Krzysztof
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[3] Mt Sinai Hosp, New York, NY 10029 USA
[4] Icahn Sch Med, Dept Dev & Regenerat Biol, New York, NY USA
[5] Icahn Sch Med Mt Sinai, Genet & Genom Sci, New York, NY 10029 USA
[6] Icahn Sch Med Mt Sinai, Dept Hematol & Med Oncol, New York, NY 10029 USA
[7] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA
[8] Icahn Sch Med Mt Sinai, Hematol & Med Oncol, New York, NY 10029 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
10.1200/jco.2015.33.3_suppl.568
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
568
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Characterization of NTRK alterations in metastatic colorectal cancer.
    Karan, Canan
    Tan, Elaine
    Sarfraz, Humaira
    Walko, Christine Marie
    Kim, Richard D.
    Knepper, Todd C.
    Sahin, Ibrahim Halil
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15569 - E15569
  • [42] Lung cancer. Molecular pathology and personalized therapy
    Schultheis, A.
    Wolf, J.
    Buettner, R.
    INTERNIST, 2013, 54 (02): : 179 - +
  • [43] Endocrine therapy metastatic prostate cancer.
    Ruffion, A
    Fontaine, E
    Staerman, F
    PROGRES EN UROLOGIE, 2003, 13 (02): : 334 - 341
  • [44] Metastasectomy and BRAF mutation: An analysis of survival outcome in metastatic colorectal cancer.
    Prasanna, Thiru
    Wong, Rachel
    Price, Timothy Jay
    Shapiro, Jeremy David
    Tie, Jeanne
    Wong, Hui-Li
    Nott, Louise M.
    Roder, David
    Lee, Margaret
    Kosmider, Suzanne
    Jalali, Azim
    Burge, Matthew E.
    Padbury, Robert
    Maddern, Guy
    Moore, James
    Carruthers, Scott
    Sorich, Michael
    Karapetis, Christos Stelios
    Gibbs, Peter
    Yip, Desmond
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [45] Preclinical development of tumor-infiltrating lymphocyte therapy for metastatic colorectal cancer.
    Sakellariou-Thompson, Donastas
    Forget, Marie-Andree
    Roszik, Jason
    Jackson, Kyle R.
    Kim, Young Uk
    Crosby, Shadarra
    Hurd, Mark W.
    Wu, Ji
    Jiang, Zhi-Qin
    Hwu, Patrick
    Lizee, Gregory
    Menter, David
    Kopetz, Scott
    Overman, Michael J.
    Haymaker, Cara L.
    Bernatchez, Chantale
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [46] Direct cost-survival analysis of therapies for metastatic colorectal cancer.
    Wong, Y.
    Meropol, N. J.
    Sargent, D.
    Goldberg, R.
    Beck, J. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 149S - 149S
  • [47] Analysis of the efficacy of CIK therapy in adjuvant treatment of colorectal cancer.
    Guo, Rui
    Piao, Haiyan
    Shi, Gang
    Zhang, Guirong
    Zhang, Rui
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [48] Metastatic Colorectal Cancer in the Era of Personalized Medicine: A More Tailored Approach to Systemic Therapy
    Yu, Irene S.
    Cheung, Winson Y.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 2018
  • [49] Genomic and epigenomic profiles to distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer.
    Wang, Jie
    Zuo, Ying
    Bai, Hua
    Duan, Jianchun
    Wang, Zhijie
    Li, Weihua
    Ying, Jianming
    Han, Jie-Fei
    Tian, Yanhua
    Chen, Yedan
    Shao, Yang
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [50] Novel genomic characterization in late stage colorectal cancer.
    Li, Jianxia
    Wu, Qianchao
    Zhang, Jianwei
    Hu, Huabin
    Cai, Yue
    Lin, Jiayu
    Liu, Jun
    Deng, Yanhong
    CANCER RESEARCH, 2021, 81 (13)
12345